| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NKTR over the last quarter tilts toward selling: insiders offloaded a net 5,538 shares worth roughly $336K.
Classified under Biotechnology (Health Care sector), NKTR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 57.2K | $4.37M | - | |
| Other | 21.6K | $1.65M | - | |
| Other | 16.5K | $1.26M | - | |
| Dir | 8.0K | $611.8K | - | |
| Dir | 8.0K | $611.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 73,716 | $4.65 | $342,779.40 | -18.4% | -24.8% | -84.4% | |
| Aug 16, 2022 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 10,560 | $4.76 | $50,265.60 | -2.6% | -12.8% | -83.6% | |
| Aug 16, 2022 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 3,189 | $4.76 | $15,179.64 | -1.1% | -12.8% | -83.6% | |
| Aug 16, 2022 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 2,006 | $4.76 | $9,548.56 | -0.6% | -12.8% | -83.6% | |
| Aug 16, 2022 | Robin Howard W58 | President &CEO | Sell | 13,759 | $4.76 | $65,492.84 | -1.3% | -12.8% | -83.6% | |
| May 16, 2022 | Northcott John79 | SVP &Chief Commercial Officer | Sell | 4,592 | $3.95 | $18,138.40 | -2.0% | +26.5% | -81.6% | |
| May 16, 2022 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 3,136 | $3.95 | $12,387.20 | -2.6% | +26.5% | -81.6% | |
| May 16, 2022 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 5,841 | $3.95 | $23,071.95 | -3.3% | +26.5% | -81.6% | |
| May 16, 2022 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 21,673 | $3.95 | $85,608.35 | -7.3% | +26.5% | -81.6% | |
| May 16, 2022 | Robin Howard W58 | President &CEO | Sell | 36,529 | $3.95 | $144,289.55 | -5.6% | +26.5% | -81.6% |